AstraZeneca (AZN)
Create an Alert
51.00
+0.03 +0.05%
NYSE
Jun 18, 5:00PM
BATS Real time
Currency in USD
AstraZeneca Return on Assets:
10.88% for March 31, 2013AstraZeneca Historical Return on Assets Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 10.88% |
| Dec. 31, 2012 | 12.04% |
| Sept. 30, 2012 | 12.01% |
| June 30, 2012 | 15.71% |
| March 31, 2012 | 16.47% |
| Dec. 31, 2011 | 18.52% |
| Sept. 30, 2011 | 18.53% |
| June 30, 2011 | 14.88% |
| March 31, 2011 | 14.84% |
| Dec. 31, 2010 | 14.58% |
| Sept. 30, 2010 | 14.68% |
| June 30, 2010 | 16.09% |
| March 31, 2010 | 15.82% |
| Dec. 31, 2009 | 15.01% |
| Sept. 30, 2009 | 14.81% |
| June 30, 2009 | 14.12% |
| March 31, 2009 | 14.04% |
| Dec. 31, 2008 | 12.62% |
| Sept. 30, 2008 | 12.71% |
| June 30, 2008 | 11.93% |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Return on Assets
Return on Assets (ROA) shows the rate of return (after tax) being earned on all of the firm's assets regardless of financing structure (debt vs. equity). It is a measure of how efficiently the company is using all stakeholders' assets to earn returns.
Because ROA can differ significantly across firms, ROA is often used to compare a company over time or against companies that have similar financing structures.
Learn More
AZN Return on Assets Benchmarks
| Companies | |
|---|---|
| GlaxoSmithKline | 10.07% |
| Pfizer | 8.40% |
| Merck | 5.68% |
AZN Return on Assets Rankings
| Overall |
94th percentile 874 of 16770 |
| Sector |
92nd percentile 99 of 1408 in Healthcare |
| Industry |
94th percentile 8 of 135 in Drug Manufacturers - Major |
AZN Return on Assets Range, Past 5 Years
| Minimum | 10.88% | Mar 2013 |
| Maximum | 18.53% | Sep 2011 |
| Average | 14.52% |
